申请人:Eli Lilly and Company
公开号:US04001230A1
公开(公告)日:1977-01-04
There are disclosed novel 3-(5-nitroimidazol-2-yl)-pyrazolo[3,4-d]pyrimidine compounds exhibiting utility as antibacterial and antiprotozoal agents.
披露了一种新颖的3-(5-硝基咪唑-2-基)-吡唑并[3,4-d]嘧啶化合物,具有作为抗菌和抗原虫剂的用途。